Canada’s Innovation and Skills Plan, led by Innovation, Science and Economic Development Canada, with respect to ensuring that the life sciences sector is a major focus of the government’s post-COVID recovery plan
Engagement with federal officials regarding Health Canada’s plans for the creation of a national strategy for rare diseases, national pharmacare and the Canada Drug Agency
Guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board
Regulation
Amendments to the Patented Medicines Regulations published in Canada Gazette, Part II on August 21, 2019, June 10, 2020 and January 21, 2021